These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3855433

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
    Nguyen DH, Ball ED, Varki A.
    Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Combined chemoseparation and immunoseparation of clonogenic T lymphoma cells from human bone marrow using 2'-deoxycoformycin, deoxyadenosine, 3A1 monoclonal antibody, and complement.
    Haleem A, Kurtzberg J, Olsen GA, Rhinehardt-Clark A, Leslie DS, Ray L, Smith CA, Peters WP, Haynes BF, Bast RC.
    Cancer Res; 1987 Sep 01; 47(17):4608-12. PubMed ID: 3113721
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
    Wiels J, Junqua S, Dujardin P, Le Pecq JB, Tursz T.
    Cancer Res; 1984 Jan 01; 44(1):129-33. PubMed ID: 6690030
    [Abstract] [Full Text] [Related]

  • 31. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
    Flavell DJ, Boehm DA, Noss A, Warnes SL, Flavell SU.
    Br J Cancer; 2001 Feb 01; 84(4):571-8. PubMed ID: 11207056
    [Abstract] [Full Text] [Related]

  • 32. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED, Graziano RF, Fanger MW.
    J Immunol; 1983 Jun 01; 130(6):2937-41. PubMed ID: 6574189
    [Abstract] [Full Text] [Related]

  • 33. Elimination of chemoresistant myeloma clonogenic cells from human bone marrow by monoclonal antibody and complement.
    Tong AW, Dalton WS, Tsuruo T, Fay JW, Stone MJ.
    Prog Clin Biol Res; 1990 Jun 01; 333():155-64. PubMed ID: 2308979
    [Abstract] [Full Text] [Related]

  • 34. Immunological and biological stability of immunotoxins in vivo as studied by the clearance of disulfide-linked pokeweed antiviral protein-antibody conjugates from blood.
    Ramakrishnan S, Houston LL.
    Cancer Res; 1985 May 01; 45(5):2031-6. PubMed ID: 3986759
    [Abstract] [Full Text] [Related]

  • 35. Selective removal of clonogenic neoplastic B cells from human bone marrow using anti-HLA-DQ antibodies and complement.
    Falkenburg JH, Fibbe WE, Veenhof WF, Koning F, van Eeden G, Voogt PJ, Jansen J.
    Exp Hematol; 1986 Feb 01; 14(2):101-7. PubMed ID: 2417877
    [Abstract] [Full Text] [Related]

  • 36. Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells.
    Bregni M, Lappi DA, Siena S, Formosa A, Villa S, Soria M, Bonadonna G, Gianni AM.
    J Natl Cancer Inst; 1988 Jun 01; 80(7):511-7. PubMed ID: 3259267
    [Abstract] [Full Text] [Related]

  • 37. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG, Uckun FM.
    Exp Hematol; 1993 Jun 01; 21(6):791-8. PubMed ID: 7684704
    [Abstract] [Full Text] [Related]

  • 38. Hematopoietic transforming potential of activated ras in chimeric mice.
    Hawley RG, Fong AZ, Ngan BY, Hawley TS.
    Oncogene; 1995 Sep 21; 11(6):1113-23. PubMed ID: 7566971
    [Abstract] [Full Text] [Related]

  • 39. The anti-CD20 antibody rituximab augments the immunospecific therapeutic effectiveness of an anti-CD19 immunotoxin directed against human B-cell lymphoma.
    Flavell DJ, Warnes SL, Bryson CJ, Field SA, Noss AL, Packham G, Flavell SU.
    Br J Haematol; 2006 Jul 21; 134(2):157-70. PubMed ID: 16771848
    [Abstract] [Full Text] [Related]

  • 40. Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins.
    Lemoli RM, Tazzari PL, Fortuna A, Bolognesi A, Gulati SC, Stirpe F, Tura S.
    Bone Marrow Transplant; 1994 Apr 21; 13(4):465-71. PubMed ID: 7517259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.